Clinical Trial: Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Prospective, Multi-Center Clinical Investigation to Evaluate the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL (Model MI60) Intraocular Lens
Brief Summary: This study is to evaluate the safety and effectiveness of the Bausch & Lomb Akreos TL (thin lens) intraocular lens (IOL) following implantation in adults requiring cataract surgery.
Detailed Summary:
Sponsor: Bausch & Lomb Incorporated
Current Primary Outcome: Bast Corrected Visual Acuity [ Time Frame: 24 months ]
Original Primary Outcome: Safety and effectiveness of the Bausch & Lomb Akreos TL intraocular lens. [ Time Frame: 24 months ]
Current Secondary Outcome:
- Uncorrected Visual Acuity [ Time Frame: 24 months ]
- Manifest Refraction [ Time Frame: 24 Months ]mean manifest refraction
Original Secondary Outcome:
Information By: Bausch & Lomb Incorporated
Dates:
Date Received: February 5, 2009
Date Started: September 2006
Date Completion:
Last Updated: December 7, 2011
Last Verified: December 2011